• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Challenges of Convalescent Plasma Therapy on COVID-19.

作者信息

Zhao Qian, He Yong

机构信息

Department of Pulmonary and Critical Care Medicine, Daping Hospital, Army Medical University, Chongqing, 400042, China.

Department of Pulmonary and Critical Care Medicine, Daping Hospital, Army Medical University, Chongqing, 400042, China.

出版信息

J Clin Virol. 2020 Jun;127:104358. doi: 10.1016/j.jcv.2020.104358. Epub 2020 Apr 10.

DOI:10.1016/j.jcv.2020.104358
PMID:32305026
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7146649/
Abstract
摘要

相似文献

1
Challenges of Convalescent Plasma Therapy on COVID-19.恢复期血浆疗法治疗新冠病毒肺炎面临的挑战
J Clin Virol. 2020 Jun;127:104358. doi: 10.1016/j.jcv.2020.104358. Epub 2020 Apr 10.
2
Management of COVID-19 Virus Infection by Convalescent Plasma.恢复期血浆治疗新型冠状病毒肺炎病毒感染
Iran J Allergy Asthma Immunol. 2020 May 17;19(S1):3-6. doi: 10.18502/ijaai.v19i(s1.r1).2847.
3
Convalescent plasma therapy for COVID-19: a tried-and-true old strategy?新冠康复者血浆疗法：一种久经考验的古老策略？
Signal Transduct Target Ther. 2020 Sep 15;5(1):203. doi: 10.1038/s41392-020-00310-8.
4
Challenges in the Production of Convalescent Hyperimmune Plasma in the Age of COVID-19.COVID-19时代恢复期超免疫血浆生产面临的挑战
Semin Thromb Hemost. 2020 Oct;46(7):804-806. doi: 10.1055/s-0040-1713433. Epub 2020 Jun 8.
5
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.5 例危重症 COVID-19 患者接受恢复期血浆治疗。
JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.
6
The convalescent sera option for containing COVID-19.使用康复期血清来控制新型冠状病毒肺炎。
J Clin Invest. 2020 Apr 1;130(4):1545-1548. doi: 10.1172/JCI138003.
7
Convalescent Plasma and COVID-19.康复期血浆与2019冠状病毒病
JAMA. 2020 Aug 4;324(5):524. doi: 10.1001/jama.2020.10699.
8
Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?使用康复期血浆对新冠病毒进行被动免疫治疗？证据基础和临床试验情况如何？
Transfus Apher Sci. 2020 Aug;59(4):102858. doi: 10.1016/j.transci.2020.102858. Epub 2020 Jun 27.
9
Coronavirus drugs: Using plasma from recovered patients as a treatment for COVID-19.冠状病毒药物：使用康复患者的血浆治疗新冠肺炎。
Int J Risk Saf Med. 2020;31(2):47-51. doi: 10.3233/JRS-201017.
10
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2.关于新型冠状病毒 SARS-CoV-2 的治疗性中和抗体的观点。
Int J Biol Sci. 2020 Mar 15;16(10):1718-1723. doi: 10.7150/ijbs.45123. eCollection 2020.

引用本文的文献

1
State-of-art high-performance Nano-systems for mutated coronavirus infection management: From Lab to Clinic.用于突变型冠状病毒感染管理的前沿高性能纳米系统：从实验室到临床。
OpenNano. 2022 Nov-Dec;8:100078. doi: 10.1016/j.onano.2022.100078. Epub 2022 Sep 10.
2
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update.用于COVID-19治疗的康复期血浆（高免疫球蛋白）：最新情况
Process Biochem. 2023 Apr;127:66-81. doi: 10.1016/j.procbio.2023.01.018. Epub 2023 Jan 31.
3
Factors influencing plasma donation behavior of COVID-19 recovered patients in Bangladesh: A pilot study.影响孟加拉国新冠肺炎康复患者血浆捐献行为的因素：一项试点研究。
Health Sci Rep. 2022 Dec 2;6(1):e974. doi: 10.1002/hsr2.974. eCollection 2023 Jan.
4
The effect of convalescent plasma on the treatment of COVID-19 patients in Ardabil, Iran.康复血浆对伊朗阿尔达比勒新冠肺炎患者的治疗效果。
J Educ Health Promot. 2022 Aug 25;11:266. doi: 10.4103/jehp.jehp_1439_21. eCollection 2022.
5
A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment.全面了解当前 COVID-19 控制措施：免疫原性、疫苗接种和治疗。
Biomed Pharmacother. 2022 Sep;153:113499. doi: 10.1016/j.biopha.2022.113499. Epub 2022 Aug 2.
6
Success of Current COVID-19 Vaccine Strategies vs. the Epitope Topology of SARS-CoV-2 Spike Protein-Receptor Binding Domain (RBD): A Computational Study of RBD Topology to Guide Future Vaccine Design.当前新冠病毒疫苗策略的成功与严重急性呼吸综合征冠状病毒2刺突蛋白受体结合域（RBD）的表位拓扑结构对比：一项用于指导未来疫苗设计的RBD拓扑结构计算研究
Vaccines (Basel). 2022 May 25;10(6):841. doi: 10.3390/vaccines10060841.
7
'Convalescent Plasma'- An Effective Treatment Option to Prevent Emerging nCOVID-19- A Review.“恢复期血浆”——预防新型冠状病毒肺炎的一种有效治疗选择——综述
Infect Disord Drug Targets. 2022;22(8):42-60. doi: 10.2174/1871526522666220425103031.
8
Perplexing issues for convalescent immune plasma therapy in COVID-19.新冠康复期免疫血浆疗法面临的棘手问题。
North Clin Istanb. 2021 Nov 15;8(6):634-643. doi: 10.14744/nci.2021.73604. eCollection 2021.
9
Mesenchymal stem cell therapy for COVID-19.间充质干细胞治疗新冠病毒病
Am J Stem Cells. 2021 Dec 15;10(5):79-89. eCollection 2021.
10
Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice.评估 K18-hACE2 转基因小鼠针对 Alpha、Beta 和 Delta 关注的 SARS-CoV-2 变异株的抗体介导的保护作用。
J Virol. 2022 Mar 23;96(6):e0218421. doi: 10.1128/jvi.02184-21. Epub 2022 Jan 26.

本文引用的文献

1
Convalescent plasma: new evidence for an old therapeutic tool?康复血浆：一种古老治疗手段的新证据？
Blood Transfus. 2016 Mar;14(2):152-7. doi: 10.2450/2015.0131-15. Epub 2015 Nov 6.
2
Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.恢复期血浆治疗可降低严重大流行流感 A（H1N1）2009 病毒感染患者的死亡率。
Clin Infect Dis. 2011 Feb 15;52(4):447-56. doi: 10.1093/cid/ciq106. Epub 2011 Jan 19.
3
Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?荟萃分析：用于西班牙流感肺炎的恢复期血液制品：未来治疗H5N1的方法？
Ann Intern Med. 2006 Oct 17;145(8):599-609. doi: 10.7326/0003-4819-145-8-200610170-00139. Epub 2006 Aug 29.
4
Risks and side effects of therapy with plasma and plasma fractions.血浆及血浆成分治疗的风险与副作用。
Best Pract Res Clin Haematol. 2006;19(1):169-89. doi: 10.1016/j.beha.2005.01.033.
5
Use of convalescent plasma therapy in SARS patients in Hong Kong.香港严重急性呼吸系统综合症患者康复期血浆疗法的应用。
Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6. doi: 10.1007/s10096-004-1271-9.
6
Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients.严重急性呼吸综合征（SARS）患者恢复期血浆与持续大剂量甲基强的松龙治疗的回顾性比较。
Clin Microbiol Infect. 2004 Jul;10(7):676-8. doi: 10.1111/j.1469-0691.2004.00956.x.
7
Profile of specific antibodies to the SARS-associated coronavirus.严重急性呼吸综合征相关冠状病毒特异性抗体概况
N Engl J Med. 2003 Jul 31;349(5):508-9. doi: 10.1056/NEJM200307313490520.
8
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.冠状病毒相关严重急性呼吸综合征肺炎社区暴发中的临床进展与病毒载量：一项前瞻性研究。
Lancet. 2003 May 24;361(9371):1767-72. doi: 10.1016/s0140-6736(03)13412-5.